POSTPONED - China/EU Pharmaceutical Industry Forum Wavre, Belgium
16.03.20 - 16.03.20
** Event postponed until Autumn 2020 **
The workshop covers 4 different themes, namely Pharmaceuticals in the Environment, ICH Q12 Product Life Cycle Management, Harmonisation of Chinese and European Pharmacopoeias and Pricing & Reimbursement, including HTA.
We have already got confirmation from a setup of experienced EFPIA, EMA, Commission and EDQM speakers, who are presented below.
This workshop is jointly organised by
The workshop covers 4 different themes, namely Pharmaceuticals in the Environment, ICH Q12 Product Life Cycle Management, Harmonisation of Chinese and European Pharmacopoeias and Pricing & Reimbursement, including HTA.
We have already got confirmation from a setup of experienced EFPIA, EMA, Commission and EDQM speakers, who are presented below.
- Marilena-Silvia Lungu from the EU Commission, DG Santé will present on EU Strategic Approach to Pharmaceuticals in the Environment (PIE).
- The Director of EDQM Susanne Keitel will present on Opportunities and challenges re harmonisation of European and Chinese Pharmacopoeias.
- Paulo Tozzi, member of EFPIA Pharmacopoeia group, will present on Harmonisation of Chinese and European pharmacopoeia - wishes from EFPIA.
- Bengt Mattson, co-chair of the EFPIA Pharmaceutical in the Environment (PIE-TF) will present on Eco-Pharmaco - Stewardship - A Holistic Approach to PIE.
- Edit Frénoy, Director Market Access at EFPIA will present on Health Technology Assessments in Europe.
- Pär Tellner, Team Leader, Regulatory, Drug Development and Manufacturing at EFPIA will moderate the afternoon session and the panel discussion.
- Jean-Louis Robert, EU/EMA Topic Lead ICH Q12 will present on Implementation of ICH Q12 in Europe.
- Graham Cook, EFPIA Topic Lead ICH Q12 will present on Overview and benefits of ICH Q12 guideline.
This workshop is jointly organised by